|
Delayed
Japan Exchange
10:30:00 02/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,671.00 JPY | 0.00% |
|
-0.12% | -3.41% |
| 11/05/23 | HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 20/09/21 | HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index | CI |
Company Valuation: HABA Laboratories,Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 17,225 | 8,172 | 8,811 | 7,854 | 6,580 | 6,432 |
| Change | - | -52.56% | 7.82% | -10.86% | -16.23% | -2.24% |
| Enterprise Value (EV) 1 | 15,480 | 5,078 | 6,026 | 6,249 | 3,653 | 1,835 |
| Change | - | -67.2% | 18.67% | 3.71% | -41.55% | -49.76% |
| P/E | 79.7x | -30.4x | -12.5x | -3.71x | 11.4x | 8.46x |
| PBR | 1.43x | 0.7x | 0.82x | 0.92x | 0.74x | 0.67x |
| PEG | - | 0x | -0x | -0x | -0x | 0.3x |
| Capitalization / Revenue | 1.2x | 0.63x | 0.73x | 0.64x | 0.55x | 0.53x |
| EV / Revenue | 1.08x | 0.39x | 0.5x | 0.51x | 0.3x | 0.15x |
| EV / EBITDA | 17.3x | 13x | -121x | 18.8x | 4.89x | 2.04x |
| EV / EBIT | 68.2x | -16x | -9.89x | -33.4x | 6.2x | 2.57x |
| EV / FCF | -31.5x | 3.28x | 45.8x | -6.48x | 2.95x | 1.83x |
| FCF Yield | -3.18% | 30.5% | 2.18% | -15.4% | 33.9% | 54.8% |
| Dividend per Share 2 | 40 | 40 | 40 | 40 | 40 | 40 |
| Rate of return | 0.88% | 1.85% | 1.72% | 1.93% | 2.3% | 2.35% |
| EPS 2 | 57.12 | -71.13 | -187 | -560.1 | 152.3 | 201 |
| Distribution rate | 70% | -56.2% | -21.4% | -7.14% | 26.3% | 19.9% |
| Net sales 1 | 14,307 | 12,908 | 12,038 | 12,324 | 12,061 | 12,141 |
| EBITDA 1 | 896 | 391 | -50 | 332 | 747 | 899 |
| EBIT 1 | 227 | -317 | -609 | -187 | 589 | 713 |
| Net income 1 | 216 | -269 | -707 | -2,118 | 576 | 760 |
| Net Debt 1 | -1,745 | -3,094 | -2,785 | -1,605 | -2,927 | -4,597 |
| Reference price 2 | 4,555.00 | 2,161.00 | 2,330.00 | 2,077.00 | 1,740.00 | 1,701.00 |
| Nbr of stocks (in thousands) | 3,782 | 3,782 | 3,782 | 3,782 | 3,782 | 3,781 |
| Announcement Date | 21/06/21 | 20/06/22 | 19/06/23 | 24/06/24 | 19/06/25 | 19/06/26 |
1JPY in Million2JPY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 40.04M | |
| 23.65x | 4.46x | 16.33x | 2.72% | 379B | |
| 33.35x | 5.05x | 21x | 1.76% | 260B | |
| 19.06x | 2.88x | 12.73x | 3.3% | 142B | |
| 26.11x | 3.85x | 16.12x | 2.19% | 77.45B | |
| 61.17x | 8.67x | 33.45x | 0.25% | 54.51B | |
| 38.78x | 6.15x | 27.05x | 2.43% | 47.11B | |
| 37.21x | 2.8x | 15.57x | 1.42% | 37.91B | |
| 16.93x | 2.49x | 11.53x | 4.78% | 36B | |
| 24.24x | 1.77x | 11.29x | 2.08% | 21.59B | |
| Average | 31.17x | 4.24x | 18.34x | 2.33% | 105.56B | |
| Weighted average by Cap. | 28.49x | 4.46x | 18.05x | 2.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4925 Stock
- Valuation HABA Laboratories,Inc.
Select your edition
All financial news and data tailored to specific country editions
